For citations:
Bayrasheva VK, Babenko AY, Bayramov AA, Chefu SG, Shatalov IS, Pchelin IY, Arefieva AN, Grineva EN. PROSPECTS OF NEPHROPROTECTION AGAINST TYPE 2 DIABETES USING THE DPP-4 INHIBITOR VILDAGLIPTIN. Meditsinskiy sovet = Medical Council. 2017;(3):8-16. (In Russ.) https://doi.org/10.21518/2079-701X-2017-3-8-16